After MEM completed its pivotal clinical trial in March 2025, which resulted in the Felix device being declared 'best in class", MEM has been actively seeking commercial partnerships.
MEM is clearly and actively working in this area and the conditions in USA seem ripe for a deal to occur.
So, soon means that the potential clearly and notably exists, but a defined time frame is impossible to predict.
MEM Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)